|
Volumn 9 Suppl 3, Issue , 2009, Pages
|
New thrombopoietic growth factors.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BENZOIC ACID DERIVATIVE;
ELTROMBOPAG;
FC RECEPTOR;
HYBRID PROTEIN;
HYDRAZINE DERIVATIVE;
PEPTIDE;
PYRAZOLE DERIVATIVE;
ROMIPLOSTIM;
SIGNAL PEPTIDE;
THROMBOPOIETIN;
BIOLOGICAL MODEL;
CHEMICAL MODEL;
CHEMISTRY;
CLINICAL TRIAL;
DRUG EFFECT;
HEMATOLOGY;
HUMAN;
IMMUNOLOGY;
METABOLISM;
METHODOLOGY;
REVIEW;
THROMBOCYTE COUNT;
THROMBOCYTOPENIA;
THROMBOCYTOPOIESIS;
TIME;
TREATMENT OUTCOME;
BENZOIC ACIDS;
CLINICAL TRIALS AS TOPIC;
HEMATOLOGY;
HUMANS;
HYDRAZINES;
INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS;
MODELS, BIOLOGICAL;
MODELS, CHEMICAL;
PEPTIDES;
PLATELET COUNT;
PYRAZOLES;
RECEPTORS, FC;
RECOMBINANT FUSION PROTEINS;
THROMBOCYTOPENIA;
THROMBOPOIESIS;
THROMBOPOIETIN;
TIME FACTORS;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
EID: 74049127615
PISSN: None
EISSN: 19380712
Source Type: Journal
DOI: 10.3816/clm.2009.s.034 Document Type: Review |
Times cited : (41)
|
References (84)
|